Pharmaceutical

Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal

Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.

May 29, 2024 - 04:00
Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal
Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.
Read the original article

Tags:

Previous Article

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

Next Article

QUT team receives US DoD funding for Parkinson’s treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Biden launches a new push to limit health care costs, hoping to show he can save money for families

STAT+: Biden launches a new push to limit health care c...

Jul 10, 2023

CD70 CAR-T by UTC Therapeutics for Anaplastic Large Cel...

Aug 10, 2023

STAT+: How the FDA’s pandemic flexibilities boosted mental health apps — and what happens now

STAT+: How the FDA’s pandemic flexibilities boosted men...

May 11, 2023